HomeGTTX • CNSX
add
GeneTether Therapeutics Inc
Previous close
$0.10
Day range
$0.10 - $0.10
Year range
$0.015 - $0.10
Market cap
3.87M CAD
Avg Volume
5.89K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 134.94K | 212.29% |
Net income | -128.73K | -366.76% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 966.11K | -29.04% |
Total assets | 1.02M | -30.10% |
Total liabilities | 29.42K | -2.97% |
Total equity | 986.45K | — |
Shares outstanding | 38.74M | — |
Price to book | 3.33 | — |
Return on assets | -31.82% | — |
Return on capital | -32.63% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -128.73K | -366.76% |
Cash from operations | -78.97K | -87.52% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -65.11K | 9.87% |
Free cash flow | -54.64K | -32.49% |
About
Founded
2018
Headquarters
Website
